Related Experiment Videos
[Ultrasonography-guided transrectal prostatic biopsy: indications, methods, complications. Our experience]
Roberto Borsa1, Andrea Moiso, Gabriele Fontana
1U.O.A. Urologia ASL 17, Ospedale SS Annunziata, Savigliano, Cuneo. roberto.borsa@asl17.it
Summary
Ultrasound-guided transrectal prostatic biopsy is a safe and effective diagnostic tool for prostate cancer detection. This procedure is recommended for patients with elevated PSA levels, even with a negative digital rectal exam, and has a low complication rate.
Area of Science:
- Urology
- Oncology
- Diagnostic Imaging
Background:
- Prostate biopsy indications and management vary.
- Elevated Prostate-Specific Antigen (PSA) levels necessitate further investigation.
- Digital rectal examination (DRE) can be normal despite potential prostate cancer.
Purpose of the Study:
- To evaluate the efficacy and safety of ultrasound-guided transrectal prostatic biopsy.
- To establish guidelines for prostatic biopsy indications based on PSA levels.
- To assess the complication rate of the procedure.
Main Methods:
- Ultrasound-guided transrectal prostatic biopsies were performed on patients with total PSA up to 10 ng/ml.
- Antiflogistic therapy was administered for 40 days for patients with PSA 4-10 ng/ml and a borderline PSA ratio.
- A standardized ten-biopsy mapping technique was employed using specific ultrasound equipment and needles.
- Biopsies were generally performed on patients under 75 years old.
Main Results:
- Ultrasound-guided transrectal prostatic biopsy is indicated for patients with PSA up to 10 ng/ml, even with a negative DRE.
- A specific protocol involving antiflogistic therapy was used for patients in the PSA gray zone.
- The diagnostic procedure demonstrated a low complication rate of 6%.
Conclusions:
- Ultrasound-guided transrectal prostatic biopsy is a safe and well-tolerated procedure.
- The biopsy technique is effective for diagnosing prostate cancer.
- The low complication rate supports its use as a standard diagnostic tool.